BRIEF published on 09/17/2025 at 07:35, 1 month 22 days ago Sensorion announces its 2025 half-year results Funding Gene Therapy SENS-401 SENS-501 2025 Results
PRESS RELEASE published on 09/17/2025 at 07:30, 1 month 22 days ago Inside Information / News release on accounts, results Sensorion reports 2025 half-year results, corporate update, and availability of half-year report. Progress in gene therapy programs for hearing loss disorders discussed Clinical Trials Gene Therapy Sensorion Hearing Loss Disorders 2025 Half-Year Results
BRIEF published on 09/04/2025 at 07:35, 2 months 5 days ago Sensorion to Present at 60th Inner Ear Biology Workshop Biotechnology Gene Therapy Sensorion Hearing Loss Inner Ear Biology Workshop
PRESS RELEASE published on 09/04/2025 at 07:30, 2 months 5 days ago Inside Information / Other news releases Sensorion announces participation in the 60th Annual Inner Ear Biology Workshop presenting gene therapy research for hearing loss disorders Research Gene Therapy Sensorion Hearing Loss Disorders Inner Ear Biology Workshop
BRIEF published on 08/15/2025 at 07:35, 2 months 25 days ago Sensorion Strengthens its Liquidity Contract with Kepler Cheuvreux Liquidity Biotechnology Euronext Kepler Cheuvreux Sensorion
PRESS RELEASE published on 08/15/2025 at 07:30, 2 months 25 days ago Inside Information / Other news releases Sensorion increases resources allocated to liquidity contract with Kepler Cheuvreux by €60,000 to enhance liquidity of shares on Euronext Paris. The move is in accordance with AMF Decision No. 2021-01 Euronext Paris Liquidity Contract Kepler Cheuvreux AMF Decision Sensorion
BRIEF published on 07/31/2025 at 09:22, 3 months 9 days ago Sensorion Announces Participation in Investor Conferences Biotechnology Investor Conferences Sensorion Hearing Therapies September-October 2025
BRIEF published on 07/01/2025 at 07:35, 4 months 8 days ago Sensorion Reports Positive Preliminary Data from Audiogene Phase 1/2 Trial Gene Therapy Sensorion SENS-501 Congenital Deafness Audiogene Trial
PRESS RELEASE published on 07/01/2025 at 07:30, 4 months 8 days ago Inside Information / Other news releases Sensorion announces positive data from the first cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial, showing safety and hearing improvement in toddlers. Second cohort recruitment near completion Gene Therapy Clinical Trial Sensorion Audiogene Hearing Improvement
BRIEF published on 05/13/2025 at 07:35, 5 months 27 days ago Sensorion Announces Approval of Shareholders’ Meeting Resolutions Biotechnology Gene Therapy Shareholder Resolutions Sensorion Hearing Loss Therapy
Published on 11/08/2025 at 17:40, 1 day 12 hours ago New to The Street to Broadcast Show Number 698 on Bloomberg - Saturday, November 8, 2025, at 6:30 PM EST
Published on 11/08/2025 at 00:00, 2 days 5 hours ago Onco-Innovations' Inka Health Publishes Framework on Transportability of Real-World Evidence and Use in Health Technology Assessment
Published on 11/07/2025 at 22:30, 2 days 7 hours ago Nextech3D.ai and Arway Provide Business Combination Update
Published on 11/07/2025 at 22:01, 2 days 7 hours ago Silver Tiger Announces Receipt of All Required Approvals to Construct the El Tigre Stockwork Zone Silver-Gold Project
Published on 11/10/2025 at 03:40, 2 hours 12 minutes ago ZPMC Signs RMB 2.8 Billion in Procurement Contracts with 12 Global Suppliers at CIIE, Setting a New Record
Published on 11/09/2025 at 22:45, 7 hours 7 minutes ago Issin and Riko Make History for Japan, Winning Red Bull BC One 2025 World Final at Tokyo's Ryogoku Kokugikan Sumo Arena
Published on 11/09/2025 at 05:45, 1 day ago CGTN: How China's high-standard opening up fuels high-quality development
Published on 11/08/2025 at 17:00, 1 day 12 hours ago Sharing Prosperity in the Intelligent Era: 2025 China International Intelligent Communication Forum Held in Wuxi
Published on 11/07/2025 at 23:28, 2 days 6 hours ago Agreements Concerning Strategic Partnership between Leclanché and Pinnacle International Venture Capital Limited have Ended
Published on 11/07/2025 at 18:00, 2 days 11 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2025
Published on 11/07/2025 at 17:40, 2 days 12 hours ago Eiffage wins the public-private partnership contract for construction of a new prison facility in Vresse sur Semois (Belgium), for a total investment amount of €171 million
Published on 11/07/2025 at 17:35, 2 days 12 hours ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2025
